Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041 · see citing works

<tt>edgeR</tt> : a Bioconductor package for differential expression analysis of digital gene expression data

Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · see citing works

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works

The central role of the propensity score in observational studies for causal effects

ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw937 · Cited by 6,980 · see citing works

Fast gene set enrichment analysisPreprint

Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,742 · see citing works

Ferroptosis as a p53-mediated activity during tumour suppression

Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · see citing works

p53 in health and disease

Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works

TP53 mutations in human cancers: origins, consequences, and clinical use.

Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · see citing works

Natural Innate and Adaptive Immunity to Cancer

Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,095 · see citing works

Putting p53 in context

Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906 · see citing works

Policy: NIH to balance sex in cell and animal studies

Clayton, J. A., & Collins, F. S. (2014) · Nature · doi:10.1038/509282a · Cited by 1,816 · see citing works

Unravelling mechanisms of p53-mediated tumour suppression

Bieging-Rolett, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3711 · Cited by 1,389 · see citing works

MDM2, MDMX and p53 in oncogenesis and cancer therapy

Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works

The DNA sequence of the human X chromosome

Ross, M. T., Grafham, D. V., Coffey, A. J., Scherer, S., McLay, K., Muzny, D., Platzer, M., Howell, G. R., Burrows, C., Bird, C. P., et al. (2005) · Nature · doi:10.1038/nature03440 · Cited by 1,129 · see citing works

P53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works

Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Taylor, A. M., Shih, J., Ha, G., Gao, G. F., Zhang, X., Berger, A. C., Schumacher, S. E., Wang, C., Hu, H., Liu, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.007 · Cited by 1,027 · see citing works

Mutant p53 as a guardian of the cancer cell

Mantovani, F., Collavin, L., & Sal, G. D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0246-9 · Cited by 779 · see citing works

The role of p53 in cancer drug resistance and targeted chemotherapy

Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2016) · Oncotarget · doi:10.18632/oncotarget.13475 · Cited by 590 · see citing works

Posttranslational Modification of p53: Cooperative Integrators of FunctionPreprint

Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 487 · see citing works

Oncotator: Cancer Variant Annotation Tool

Ramos, A. H., Lichtenstein, L., Gupta, M., Lawrence, M. S., Pugh, T. J., Saksena, G., Meyerson, M. M., & Getz, G. A. (2015) · Human Mutation · doi:10.1002/humu.22771 · Cited by 485 · see citing works

Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias

Dunford, A. J., Weinstock, D. M., Savova, V., Schumacher, S. E., Cleary, J. P., Yoda, A., Sullivan, T. J., Hess, J. M., Gimelbrant, A. A., Beroukhim, R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3726 · Cited by 459 · see citing works

Invasive Cancer Incidence, 2004–2013, and Deaths, 2006–2015, in Nonmetropolitan and Metropolitan Counties — United States

Henley, S. J., Anderson, R. N., Thomas, C. C., Massetti, G. M., Peaker, B., & Richardson, L. C. (2017) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6614a1 · Cited by 420 · see citing works

Genes that escape from X inactivation

Berletch, J. B., Yang, F., Xu, J., Carrel, L., & Disteche, C. M. (2011) · Human Genetics · doi:10.1007/s00439-011-1011-z · Cited by 384 · see citing works

Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation

Wutz, A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3035 · Cited by 361 · see citing works

A Weighting Analogue to Pair Matching in Propensity Score Analysis

Li, L., & Greene, T. (2013) · The International Journal of Biostatistics · doi:10.1515/ijb-2012-0030 · Cited by 352 · see citing works

TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants

Sulak, M. A., Fong, L., Mika, K. M., Chigurupati, S., Yon, L., Mongan, N. P., Emes, R. D., & Lynch, V. J. (2016) · eLife · doi:10.7554/elife.11994 · Cited by 342 · see citing works

MDM4 is a key therapeutic target in cutaneous melanoma

Gembarska, A., Luciani, F., Fedele, C., Russell, E. A., Dewaele, M., Villar, S., Zwolinska, A., Haupt, S., de Lange, J., Yip, D., et al. (2012) · Nature Medicine · doi:10.1038/nm.2863 · Cited by 327 · see citing works

Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients

Yuan, Y., Liu, L., Chen, H., Wang, Y., Xu, Y., Mao, H., Li, J., Mills, G. B., Shu, Y., Li, L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.001 · Cited by 325 · see citing works

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma

Koschmann, C. J., Calinescu, A., Núñez, F. J., Mackay, A. G., Fazal-Salom, J., Thomas, D., Mendez, F., Kamran, N., Dzaman, M., Mulpuri, L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac8228 · Cited by 279 · see citing works

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., & Schneider, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510834103 · Cited by 257 · see citing works

CDK8 Is a Stimulus-Specific Positive Coregulator of p53 Target Genes

Donner, A. J., Szostek, S. A., Hoover, J. M., & Espinosa, J. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.026 · Cited by 253 · see citing works

eXclusion: Toward Integrating the X Chromosome in Genome-wide Association Analyses

Wise, A. L., Gyi, L., & Manolio, T. A. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.017 · Cited by 237 · see citing works

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

Higashitsuji, H., Higashitsuji, H., Itoh, K., Sakurai, T., Nagao, T., Sumitomo, H., Masuda, T., Dawson, S. P., Shimada, Y., Mayer, R. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.006 · Cited by 228 · see citing works

Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA

Léveillé, N., Melo, C. A., Rooijers, K., Díaz-Lagares, A., Melo, S. A., Korkmaz, G., Lopes, R., Moqadam, F. A., Maia, A. R., Wijchers, P. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7520 · Cited by 183 · see citing works

Cancer cells preferentially lose small chromosomes

Duijf, P. H. G., Schultz, N. D., & Benezra, R. (2012) · International Journal of Cancer · doi:10.1002/ijc.27924 · Cited by 170 · see citing works

The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it

Savoy, R. M., & Ghosh, P. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0364 · Cited by 170 · see citing works

Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males

Sun, T., Warrington, N. M., Luo, J. R., Brooks, M. D., Dahiya, S. M., Snyder, S. C., Sengupta, R., & Rubin, J. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71048 · Cited by 162 · see citing works

Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies

Guerrero, S. X., López‐Cortés, A., Indacochea, A., Garcí­a-Cárdenas, J. M., Zambrano, A. K., Cabrera‐Andrade, A., Guevara‐Ramírez, P., González, D. A., Leone, P., & Paz‐y‐Miño, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-32264-x · Cited by 161 · see citing works

Why females are mosaics, x-chromosome inactivation, and sex differences in disease

Migeon, B. R. (2007) · Gender Medicine · doi:10.1016/s1550-8579(07)80024-6 · Cited by 152 · see citing works

The importance of p53 pathway genetics in inherited and somatic cancer genomes

Stracquadanio, G., Wang, X., Wallace, M. D., Grawenda, A. M., Zhang, P., Hewitt, J., Zerón-Medina-Cuairán, J., Castro-Giner, F., Tomlinson, I. P. M., Goding, C. R., et al. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.15 · Cited by 141 · see citing works

TP53mutations, expression and interaction networks in human cancers

Wang, X., & Sun, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.13483 · Cited by 132 · see citing works

The Roles of Initiating Truncal Mutations in Human Cancers: The Order of Mutations and Tumor Cell Type Matters

Levine, A. J., Jenkins, N. A., & Copeland, N. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.11.009 · Cited by 121 · see citing works

Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage

Moudrý, P., Lukas, C., Macůrek, L., Hanzlíková, H., Hodný, Z., Lukas, J., & Bártek, J. (2012) · Cell Cycle · doi:10.4161/cc.19978 · Cited by 120 · see citing works

Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53

Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 118 · see citing works

Variable escape from X‐chromosome inactivation: Identifying factors that tip the scales towards expression

Peeters, S. B., Cotton, A. M., & Brown, C. J. (2014) · BioEssays · doi:10.1002/bies.201400032 · Cited by 103 · see citing works

Sex difference in neural tube defects in p53‐null mice is caused by differences in the complement of X not Y genes

Chen, X., Watkins, R., Délot, E. C., Reliene, R., Schiestl, R. H., Burgoyne, P. S., & Arnold, A. P. (2007) · Developmental Neurobiology · doi:10.1002/dneu.20581 · Cited by 90 · see citing works

Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics

Zhao, Y., Bernard, D., & Wang, S. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.4 · Cited by 89 · see citing works

DNA damage-induced histone H1 ubiquitylation is mediated by HUWE1 and stimulates the RNF8-RNF168 pathway

Mandemaker, I. K., van Cuijk, L., Janssens, R. C., Lans, H., Bezstarosti, K., Hoeijmakers, J. H. J., Demmers, J., Vermeulen, W., & Marteijn, J. A. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-15194-y · Cited by 87 · see citing works

The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma

Phung, B., Cieśla, M., Sanna, A. M., Guzzi, N., Beneventi, G., Ngoc, P. C. T., Lauss, M., Cabrita, R., Cordero, E., Bosch, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.069 · Cited by 82 · see citing works

Analysis-ready standardized TCGA data from Broad GDAC Firehose 2016_01_28 run

Broad Institute TCGA Genome Data Analysis Center (2016) · The Broad Institute - Data Science Platform · doi:10.7908/c11g0km9 · Cited by 73 · see citing works

Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis

Puca, R., Nardinocchi, L., Starace, G., Rechavi, G., Sacchi, A., Givol, D., & D’Orazi, G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.015 · Cited by 70 · see citing works

Cooperative p16 and p21 action protects female astrocytes from transformation

Kfoury, N., Sun, T., Yu, K., Rockwell, N., Tinkum, K. L., Qi, Z., Warrington, N. M., McDonald, P. R., Roy, A., Weir, S. J., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0513-5 · Cited by 70 · see citing works

The long and the short of it: the MDM4 tail so far

Haupt, S., Mejía-Hernández, J. O., Vijayakumaran, R., Keam, S. P., & Haupt, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz007 · Cited by 69 · see citing works

The E1 ubiquitin-activating enzyme Uba1 inDrosophilacontrols apoptosis autonomously and tissue growth non-autonomously

Lee, T. V., Ding, T., Chen, Z., Rajendran, V. G., Scherr, H., Lackey, M., Bolduc, C., & Bergmann, A. (2007) · Development · doi:10.1242/dev.011288 · Cited by 67 · see citing works

The E3 ubiquitin ligase Mule acts through the ATM–p53 axis to maintain B lymphocyte homeostasis

Hao, Z., Duncan, G. S., Su, Y.-W., Li, W. Y., Silvester, J., Hong, C., You, H., Brenner, D., Gorrini, C., Haight, J., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111363 · Cited by 63 · see citing works

MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs

Peche, L. Y., Scolz, M., Ladelfa, M. F., Monte, M., & Schneider, C. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.173 · Cited by 62 · see citing works

Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects

Delbridge, A. R. D., Kueh, A. J., Ke, F., Zamudio, N., El-Saafin, F., Jansz, N., Wang, G., Iminitoff, M., Beck, T. J., Haupt, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.048 · Cited by 61 · see citing works

Lifestyle behaviors among US cancer survivors

Mowls, D. S., Brame, L. S., Martinez, S. A., & Beebe, L. A. (2016) · Journal of Cancer Survivorship · doi:10.1007/s11764-016-0515-x · Cited by 59 · see citing works

Cancer/Testis Antigen CAGE Exerts Negative Regulation on p53 Expression through HDAC2 and Confers Resistance to Anti-cancer Drugs

Kim, Y., Park, H., Park, D., Lee, Y., Choe, J., Hahn, J.-H., Lee, H., Kim, Y.-M., & Jeoung, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095950 · Cited by 58 · see citing works

Phosphorylation of p53 by TAF1 Inactivates p53-Dependent Transcription in the DNA Damage Response

Wu, Y., Lin, J., Piluso, L. G., Dhahbi, J. M., Bobadilla, S., Spindler, S. R., & Liu, X. E. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.10.031 · Cited by 58 · see citing works

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer

Xie, J., Li, Y., Jiang, K., Hu, K., Zhang, S., Dong, X., Dai, X., Liu, L., Zhang, T., Yang, K., et al. (2017) · Theranostics · doi:10.7150/thno.21963 · Cited by 52 · see citing works

The Role of the p53 Protein in Stem-Cell Biology and Epigenetic RegulationPreprint

Levine, A. J., Puzio‐Kuter, A. M., Chan, C. S., & Hainaut, P. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026153 · Cited by 50 · see citing works

Accounting for sex in the genome

(2017) · Nature Medicine · doi:10.1038/nm.4445 · Cited by 49 · see citing works

Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

Warren, R. S., Atreya, C. E., Niedzwiecki, D., WEINBERG, V. K., Donner, D. B., Mayer, R. J., Goldberg, R. M., Compton, C. C., Zuraek, M. B., Ye, C., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0351 · Cited by 45 · see citing works

Human UTP14a promotes colorectal cancer progression by forming a positive regulation loop with c-Myc

Zhang, J., Ren, P., Xu, D., Liu, X., Liu, Z., Zhang, C., Li, Y., Wang, L., Du, X., & Xing, B. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.010 · Cited by 45 · see citing works

DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X Loss

Chan, C.-H., Chen, C., Lee, Y. W., & You, L. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0551 · Cited by 41 · see citing works

A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation

Hu, L., Wang, J., Liu, Y., Zhang, Y., Zhang, L., Kong, R., Zheng, Z., Du, X., & Ke, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157842 · Cited by 39 · see citing works

DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation

Yi, J., Lu, G. X., Li, L., Wang, X., Cao, L., Lin, M. T., Zhang, S., & Shao, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv325 · Cited by 38 · see citing works

Negative auto-regulators trap p53 in their web

Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 36 · see citing works

Mutation of the Gene Encoding the Ubiquitin Activating Enzyme Uba1 Causes Tissue Overgrowth in Drosophila

Pfleger, C. M., Harvey, K. F., Yan, H., & Hariharan, I. K. (2007) · Fly · doi:10.4161/fly.4285 · Cited by 35 · see citing works

Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy

Noon, A. P., Polański, R., Elfert, A. Y., Kalirai, H., Shawki, H., Campbell, F., Dodson, A., Eccles, R. M., Lloyd, B. H., Sibson, D. R., et al. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10433.x · Cited by 34 · see citing works

Inactivation of X-Linked Tumor Suppressor Genes in Human Cancer

Liu, R., Kain, M., & Wang, L. (2012) · Future Oncology · doi:10.2217/fon.12.26 · Cited by 34 · see citing works

RAD6 Regulates the Dosage of p53 by a Combination of Transcriptional and Posttranscriptional Mechanisms

Chen, S., Wang, D.-L., Liu, Y., Zhao, L., & Sun, F.-L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05966-11 · Cited by 32 · see citing works

Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells

Terashima, M., Ishimura, A., Wanna-udom, S., & Suzuki, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.048 · Cited by 31 · see citing works

Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants

Vicente, C. T., Edwards, S. L., Hillman, K. M., Kaufmann, S., Mitchell, H., Bain, L., Glubb, D. M., Lee, J. S., French, J. D., & Ferreira, M. A. R. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.010 · Cited by 29 · see citing works

Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner

Haupt, S., Mitchell, C., Corneille, V., Shortt, J., Fox, S. B., Pandolfi, P. P., Castillo-Martín, M., Bonal, D. M., Cordon-Carlo, C., Lozano, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.24805 · Cited by 29 · see citing works

Modulation of immune responses by the tumor suppressor p53

Lowe, J. M., Shatz, M., Resnick, M. A., & Menéndez, D. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.2 · Cited by 29 · see citing works

High expression of ubiquitin-conjugating enzyme E2A predicts poor prognosis in hepatocellular carcinoma

Shen, J., Fu, S., Ju, L., Wang, Y., Dai, F., Liu, Z.-X., Ji, H., Shao, J., & Bian, Z. (2018) · Oncology Letters · doi:10.3892/ol.2018.8189 · Cited by 21 · see citing works

Protein serine/threonine phosphatase PPEF-1 suppresses genotoxic stress response via dephosphorylation of PDCD5

Park, S., Seo, J., Choi, H., Oh, H.-J., Guk, G., Lee, Y., Lee, J., Jun, W. J., Choi, K., & Yoon, H. (2017) · Scientific Reports · doi:10.1038/srep39222 · Cited by 19 · see citing works

Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling

Kumbhar, R., Vidal-Eychenié, S., Kontopoulos, D. ‐. G., Larroque, M., Larroque, C., Basbous, J., Κοσσίδα, Σ., Ribeyre, C., & Constantinou, A. (2018) · Life Science Alliance · doi:10.26508/lsa.201800096 · Cited by 19 · see citing works

Excess cancer in men—a call for an increased research focus

Cook, M. B. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.37 · Cited by 14 · see citing works

Overexpression of MAGEA2 has a prognostic significance and is a potential therapeutic target for patients with lung cancer

Ujiie, H., Kato, T., Lee, D., Hu, H., Fujino, K., Kaji, M., Kaga, K., Matsui, Y., & Yasufuku, K. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3984 · Cited by 12 · see citing works

Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins

Haupt, Y., & Blandino, G. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00170 · Cited by 3 · see citing works

Understanding the complexity of p53 in a new era of tumor suppression

Liu, Y., Su, Z., Tavana, O., & Gu, W. J. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 519 · see citing works

Sex differences in cancer mechanisms

Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P. I., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 369 · see citing works

Sex disparities matter in cancer development and therapy

Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B., & Haupt, Y. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00348-y · Cited by 333 · see citing works

Genome-Wide Sex and Gender Differences in Cancer

Lopes‐Ramos, C. M., Quackenbush, J. F., & DeMeo, D. L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.597788 · Cited by 162 · see citing works

The spectrum of sex differences in cancer

Rubin, J. B. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.01.013 · Cited by 128 · see citing works

Sex and gender perspectives in colorectal cancer

Baraibar, I., Ros, J., Gonzalez, N. S., Salvà, F., Garcia, A. R., Castells, M. R., Tabernero, J. M., & Élez, E. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101204 · Cited by 121 · see citing works

Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction

Fujihara, K. M., Zhang, B. Z., Jackson, T. D., Ogunkola, M. O., Nijagal, B., Milne, J. V., Sallman, D. A., Ang, C.-S., Nikolic, I., Kearney, C. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abm9427 · Cited by 103 · see citing works

Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions

Doshi, B., Athans, S. R., & Woloszynska‐Read, A. (2023) · Oncogenesis · doi:10.1038/s41389-023-00489-9 · Cited by 88 · see citing works

Association of T P53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

Deneka, A. Y., Baca, Y., Serebriiskii, I. G., Nicolas, É., Parker, M. I., Nguyen, T. T., Xiu, J., Korn, W. M., Demeure, M. J., Wise-Draper, T. M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4316 · Cited by 84 · see citing works

Sex difference in human diseases: mechanistic insights and clinical implications

Shi, Y., Ma, J., Li, S.-J., Liu, C., Liu, Y.-N., Chen, J., Liu, N.-N., Liu, S.-M., & Huang, H. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01929-7 · Cited by 71 · see citing works

The Privatization Challenge: A Strategic, Legal, and Institutional Analysis of International Experience

Guislain, P. (1997) · Cited by 71 · see citing works

Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies

Sakuma, M., Blombery, P. A., Meggendorfer, M., Haferlach, C., Lindauer, M., Martens, U. M., Kern, W., Haferlach, T., & Walter, W. (2023) · Leukemia · doi:10.1038/s41375-023-01857-5 · Cited by 66 · see citing works

X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis

Tricarico, R., Nicolas, É., Hall, M. J., & Golemis, E. A. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1741 · Cited by 60 · see citing works

TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival

Freudenstein, D., Litchfield, C., Caramia, F., Wright, G. M., Solomon, B., Ball, D., Keam, S. P., Neeson, P. J., Haupt, Y., & Haupt, S. (2020) · Cancers · doi:10.3390/cancers12061535 · Cited by 44 · see citing works

Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma

Kfoury, N., Qi, Z., Prager, B. C., Wilkinson, M., Broestl, L., Berrett, K., Moudgil, A., Sankararaman, S., Chen, X., Gertz, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017148118 · Cited by 40 · see citing works

Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity

Credendino, S. C., Neumayer, C., & Cantone, I. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.06.016 · Cited by 35 · see citing works

Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy

Cardano, M., Buscemi, G., & Zannini, L. (2022) · iScience · doi:10.1016/j.isci.2022.103875 · Cited by 34 · see citing works

Connecting the mechanisms of tumor sex differences with cancer therapy

Li, H., Jiang, W., Liu, S., Yang, M., Chen, S., Pan, Y., & Cui, M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04723-1 · Cited by 31 · see citing works

Sex dimorphism in the tumor microenvironment – From bench to bedside and back

He, F., Furones, A. R., Landegren, N., Fuxe, J., & Sarhan, D. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.007 · Cited by 31 · see citing works

Sex Differences in Glioblastoma—Findings from the Swedish National Quality Registry for Primary Brain Tumors between 1999–2018

Tavelin, B., & Malmström, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030486 · Cited by 26 · see citing works

The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis

Chen, J., Clarke, R. A., Haddad, A. F., Wang, E. J., Lacroix, M., Sarkar, I. N., Zand, R., Chen, E. S., & Toms, S. A. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03940-2 · Cited by 25 · see citing works

Measuring and modelling tumour heterogeneity across scales

Beeghly, G. F., Shimpi, A. A., Riter, R. N., & Fischbach, C. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00087-9 · Cited by 26 · see citing works

Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer

Liu, B., Zhou, M., Li, X., Zhang, X., Wang, Q., Liu, L., Yang, M., Yang, D., Guo, Y. H., Zhang, Q., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03727-3 · Cited by 23 · see citing works

Oxidative stress and gender disparity in cancer

Kim, S. Y. (2022) · Free Radical Research · doi:10.1080/10715762.2022.2038789 · Cited by 23 · see citing works

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity

Haupt, S., & Haupt, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.632719 · Cited by 22 · see citing works

Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review

Huang, Y., Cho, H. J., Stranger, B. E., & Huang, R. S. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-1013 · Cited by 22 · see citing works

Sexual Differentiation Specifies Cellular Responses to DNA Damage

Broestl, L., & Rubin, J. B. (2021) · Endocrinology · doi:10.1210/endocr/bqab192 · Cited by 20 · see citing works

Sex, immunity, and cancer

Pinto, J. A., Araujo, J. M., & Gómez, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188647 · Cited by 20 · see citing works

Let’s talk about sex: A biological variable in immune response against melanoma

Dakup, P., Greer, A. J., & Gaddameedhi, S. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13028 · Cited by 20 · see citing works

Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis

Rockwell, N., Yang, W., Warrington, N. M., Staller, M. V., Griffith, M., Griffith, O. L., Gurnett, C. A., Cohen, B. A., Baldridge, D., & Rubin, J. B. (2021) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0026 · Cited by 20 · see citing works

Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor

Zhao, J., Wang, Q., Tan, A. F., Loh, C. J. L., & Toh, H. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1416941 · Cited by 19 · see citing works

Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital

Simarro, J., Pérez-Simó, G., Mancheño, N., Ansótegui, E., Muñoz-Núñez, C. F., Gómez‐Codina, J., Juan, Ó., & Palanca, S. (2023) · Cancers · doi:10.3390/cancers15061705 · Cited by 18 · see citing works

Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy

Grahovac, J., Djurić, A., Tanić, M., & Krivokuća, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312669 · Cited by 17 · see citing works

UBA1 dysfunction in VEXAS and cancer

Sakuma, M., Haferlach, T., & Walter, W. (2024) · Oncotarget · doi:10.18632/oncotarget.28646 · Cited by 16 · see citing works

Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma

Zhang, G., Wang, X., Jia, J., Zuo, Z., Wang, L., Gao, S., Xue, L., & Xue, Q. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-562 · Cited by 16 · see citing works

Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population

Yang, H., Wang, X., Wang, J., Zhao, F., Fan, J., Qiao, Y., Taylor, P. R., & Abnet, C. C. (2022) · International Journal of Cancer · doi:10.1002/ijc.34160 · Cited by 14 · see citing works

Sex as a biological variable in ageing: insights and perspectives on the molecular and cellular hallmarks

García, J. H. G. F., Valsecchi, C. I. K., & Basilicata, M. F. (2024) · Open Biology · doi:10.1098/rsob.240177 · Cited by 15 · see citing works

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

Özdemir, B. C., Richters, A., da Silva, C. E., & Berner, A. (2023) · iScience · doi:10.1016/j.isci.2023.106212 · Cited by 14 · see citing works

Establishing the Link between X-Chromosome Aberrations and TP53 Status, with Breast Cancer Patient Outcomes

Caramia, F., Speed, T. P., Shen, H., Haupt, Y., & Haupt, S. (2023) · Cells · doi:10.3390/cells12182245 · Cited by 13 · see citing works

Sex specific regulation of TSPY-Like 2 in the DNA damage response of cancer cells

Cardano, M., Magni, M., Alfieri, R. R., Chan, S. Y., Sabbioneda, S., Buscemi, G., & Zannini, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05722-2 · Cited by 13 · see citing works

Next-Generation Sequencing in Public Healthcare NSCLC Management: Molecular Profiles, Actionable Alterations, and Survival Benefits

García, R., Torres, D., & Vázquez, C. (2024) · Asian journal of Current Research in Clinical Cancer · doi:10.51847/d8injqfgck · Cited by 12 · see citing works

Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study

Abe, S., Kawai, K., Nozawa, H., Sasaki, K., Murono, K., Emoto, S., Ozawa, T., Yokoyama, Y., Nagai, Y., Anzai, H., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09615-z · Cited by 12 · see citing works

The sex‐dependent role of the androgen receptor in glioblastoma: results of molecular analyses

Łysiak, M., Trybuła, M., Mudaisi, M., Bratthäll, C., Strandéus, M., Milos, P., Hallbeck, M., & Malmström, A. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13262 · Cited by 11 · see citing works

Food abundance in men before puberty predicts a range of cancers in grandsons

Vågerö, D. H., Cederström, A., & van den Berg, G. J. (2022) · Nature Communications · doi:10.1038/s41467-022-35217-1 · Cited by 11 · see citing works

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas

Kirtane, K., John, M. A. S., Fuentes, H. E., Patel, S. P., Mardiros, A., Han, X., Ng, E. W.-C., Go, W. Y., Wong, D. J. L., Sunwoo, J. B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247259 · Cited by 11 · see citing works

Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice

Shea, L. K., Akhave, N. S., Sutton, L. A., Compton, L. A., York, C. R., Ramakrishnan, S. M., Miller, C. A., Wartman, L. D., & Chen, D. Y. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.08.037 · Cited by 10 · see citing works

Sex differences in cancer incidence among solid organ transplant recipients

Jackson, S. S., Pfeiffer, R. M., Hsieh, M., Li, J., Madeleine, M. M., Pawlish, K. S., Zeng, Y., Yu, K. J., & Engels, E. A. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad224 · Cited by 10 · see citing works

miRNA-mediated regulation of clock gene expression in men and women with colorectal cancer and possible consequences for disease management

Herichová, I. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100784 · Cited by 9 · see citing works

Gender and sex interactions are intrinsic components of cancer phenotypes

Rubin, J. B. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00829-4 · Cited by 8 · see citing works

Identification of Genetic Variants Associated with Sex-Specific Lung-Cancer Risk

Shi, X., Young, S., & Morahan, G. (2021) · Cancers · doi:10.3390/cancers13246379 · Cited by 8 · see citing works

Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer

Alhebshi, H. M., Tian, K., Patnaik, L., Taylor, R., Bezecny, P., Hall, C., Muller, P. A. J., Safari, N., Creamer, D. P. M., Demonacos, C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413198 · Cited by 6 · see citing works

Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma

Huang, C., Tan, K. T., Huang, S.-F., Lu, Y., Wang, Y., Chen, S., & Tse, K. (2024) · Discover Oncology · doi:10.1007/s12672-024-01131-9 · Cited by 6 · see citing works

Association of TP53 Mutation Status and Sex with Clinical Outcome in Non–Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study

Choi, S., Kim, S. H., Lee, S., Seo, J., Kang, M.-S., Jung, E. H., Kim, S., Suh, K. J., Lee, J. Y., Kim, J., et al. (2024) · Cancer Research and Treatment · doi:10.4143/crt.2024.046 · Cited by 5 · see citing works

Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis

Kodali, N., Alomary, S., Bhattaru, A., Eldaboush, A., Schwartz, R. A., & Lipner, S. R. (2024) · Cancer Medicine · doi:10.1002/cam4.70199 · Cited by 3 · see citing works

Role of Sex in the Therapeutic Targeting of p53 Circuitry

Mancini, F., Giorgini, L., Teveroni, E., Pontecorvi, A., & Moretti, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698946 · Cited by 5 · see citing works

Distinct dosage compensations of ploidy-sensitive and -insensitive X chromosome genes during development and in diseases

Guo, M., Fang, Z., Chen, B., Songyang, Z., & Xiong, Y. (2023) · iScience · doi:10.1016/j.isci.2023.105997 · Cited by 4 · see citing works

Risk Factors of Multiple Primary Cancers Among Colorectal Cancer Survivors

Melku, M., Best, G., Winter, J. M., Thurgood, L. A., Ahmed, M. B., Kichenadasse, G., Wassie, M. M., & Symonds, E. L. (2025) · Cancers · doi:10.3390/cancers17132145 · Cited by 4 · see citing works

Sex-biased genome-editing effects of CRISPR-Cas9 across cancer cells dependent on p53 status

Guo, M., & Xiong, Y.-Y. (2023) · iScience · doi:10.1016/j.isci.2023.107529 · Cited by 4 · see citing works

Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes

Zhang, C., He, Z., Cheng, L., & Cao, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760506 · Cited by 4 · see citing works

CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research

Lu, Y., Stoof, J., Tanoé, Y. R., Walsh, N., Bijlsma, M. F., Lei, H., Chen, T., Grahovac, J., Grützmann, R., & Pilarsky, C. P. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.004 · Cited by 3 · see citing works

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2024) · eLife · doi:10.7554/elife.92774 · Cited by 3 · see citing works

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies

Cardano, M., Buscemi, G., & Zannini, L. (2025) · Cells · doi:10.3390/cells14050363 · Cited by 3 · see citing works

VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape

Singh, A., & Chaudhary, R. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103425 · Cited by 3 · see citing works

Greater TIMP ‐1 protein levels and neointimal formation represent sex‐dependent cellular events limiting aortic vessel expansion in female rats

Katat, A. A., Boudreau, L., Gagnon, E., Assous, I., Villeneuve, L. R., LeBlanc, C.-A., Bergeron, A., Sirois, M. G., El‐Hamamsy, I., & Calderone, A. (2024) · IUBMB Life · doi:10.1002/iub.2916 · Cited by 2 · see citing works

Xq24/ IL13RA1 aberrations as key drivers of female bias in primary mediastinal large B‐cell lymphoma

Marcelis, L., Allsop, R., Bempt, M. V., Debackere, K., Renard, F., Tuveri, S., Dierickx, D., Janiszewski, A., Balaton, B. P., Vets, J., et al. (2025) · HemaSphere · doi:10.1002/hem3.70200 · Cited by 2 · see citing works

Sex and stimulus-specific differences in endothelial cell senescence under hormone-free conditions

Quarder, A., Talbi, K., Bartmann, H., Beuke, E., von Kaisenberg, C., Vincente, M. M., Todorovic, S., & Melk, A. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00646.2025 · Cited by 2 · see citing works

Do clinical outcomes in individuals with malignant gliomas differ between sexes?

Goldberg, M., Frank, L.-S., Altawalbeh, G., Negwer, C., Wagner, A., Gempt, J., Meyer, B., & Aftahy, A. K. (2024) · Brain and Spine · doi:10.1016/j.bas.2024.104172 · Cited by 2 · see citing works

Brd4-bound enhancers drive cell intrinsic sex differences in glioblastomaPreprint

Kfoury, N., Qi, Z., Prager, B. C., Wilkinson, M. N., Broestl, L., Berrett, K. C., Moudgil, A., Sankararaman, S., Chen, X., Gertz, J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/199059 · Cited by 2 · see citing works

Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Ussmann, J., Bischof, L., Backhaus, D., Brauer, D., Jendro, J., Franke, G., Vučinić, V., Herling, M., Metzeler, K. H., Merz, M., et al. (2025) · Blood Cancer Journal · doi:10.1038/s41408-025-01316-7 · Cited by 1 · see citing works

Systematic analysis of non-melanoma skin cancer burden: A comparative study between China and the world from 1990 to 2021 and prediction to 2036

Liang, S., Sun, T., Jia, X., Cao, J., & Wang, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333960 · Cited by 1 · see citing works

Biological basis of sex differences in cancer and characteristics of response to immunotherapy

Yu, X., Gong, T., & Liu, Z. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2026-0003 · Cited by 1 · see citing works

The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma

Çine, N., Sen, E. A., Demir, G., Gökbayrak, M. E., Guzdolu, E., Sertdemir, N., Aydın, D., Kurtaş, Ö., Reka, S., Akkoyunlu, D. S., et al. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101819 · Cited by 1 · see citing works

Sexual dimorphism in molecular biology of cancer

Dorak, M. T. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00003-1 · Cited by 1 · see citing works

p53 mutations exhibit sex specific gain-of-function activity in gliomagenesisPreprint

Rockwell, N., Yang, W., Warrington, N., Griffith, M., Griffith, O. L., Gurnett, C. A., Cohen, B. A., Baldridge, D., & Rubin, J. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.11.448124 · Cited by 1 · see citing works

Biomarkers In Brain Tumors With Focus On Glioblastoma

Łysiak, M. (2022) · Linköping University medical dissertations · doi:10.3384/9789179291556

Comprehensively characterizing evolutionarily conserved differential dosage compensations of the X chromosome during development and in diseasesPreprint

Guo, M., Fang, Z., Chen, B., Songyang, Z., & Xiong, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.25.501478

Identifying New Regulators of Evolutionarily Conserved Differential Chromosome X Dosage CompensationPreprint

Guo, M., Fang, Z., Chen, B., Songyang, Z., & Xiong, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4178545

TP53-dependent CRISPR-Cas9 sex bias across cancer types affects MYC, PIK3CA, and SUV39H1 mediated by factors including SOX9, FOXO4, and PRC1Preprint

Guo, M., & Xiong, Y.-Y. (2023) · bioRxiv · doi:10.1101/2022.08.03.502574

Data from Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

Deneka, A. Y., Baca, Y., Serebriiskii, I. G., Nicolas, É., Parker, M. I., Nguyen, T. T., Xiu, J., Korn, W. M., Demeure, M. J., Wise-Draper, T. M., et al. (2023) · doi:10.1158/1078-0432.c.6532500

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.13.562180

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Vaysse-Zinkhöfer, W., Eldawra, E., Rakotopare, J., et al. (2024) · eLife · doi:10.7554/elife.92774.1

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomasPreprint

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2024) · eLife · doi:10.7554/elife.92774.2

Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas

Fajac, A., Simeonova, I., Leemput, J., Gabriel, M., Morin, A., Lejour, V., Hamon, A., Rakotopare, J., Vaysse-Zinkhöfer, W., Eldawra, E., et al. (2024) · eLife · doi:10.7554/elife.92774.3

Differences in the role of Gper1 in colorectal cancer progression depending on sex

Herichová, I., Reis, R. D. F., & Vanátová, D. (2025) · Oncology Letters · doi:10.3892/ol.2025.15051

Optimizing the comet assay to measure DNA damage and repair

Zheng, C. (2025) · doi:10.26481/dis.20250422cz

Sex disparity in survival outcomes of advanced gastric adenocarcinoma

Pan, M., Tong, M., Stover, J., Huang, T., Dang, A., Jiang, C., Achacoso, N. S., Bien, J. Y., Solorzano, A. V., Tse, P., et al. (2025) · BJC Reports · doi:10.1038/s44276-025-00173-y

Enhanced tumor heterogeneity mediates poor prognosis in females with TP53 mutation in lung adenocarcinoma

Mai, L., Yang, X., Shao, C., Yu, H., Du, F., Liu, J., Guan, Y., Li, H., Yang, M., Meng, H., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149083

Sex-related differences in gene expression in early-stage bladder cancer revealed by whole-transcriptome sequencing

Żeber‐Lubecka, N., Bilski, K., Dąbrowska, M., Goryca, K., Ziemska-Legięcka, J., Ostrowski, J., Dobruch, J. T., & Hennig, E. E. (2026) · BMC Cancer · doi:10.1186/s12885-026-15666-3

Space radiation promotes clonal hematopoiesis and hematologic disease upon aging in a driver gene and sex-specific manner

Evans, M. A., Doviak, H., Polizio, A. H., Cochran, J. D., Kim, L., Park, E., Thel, M. C., Xie, C. R., Srinivasan, A. R., Marino, L., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116877

Testosterone promotes growth of a type of brain tumour in young boys

Kfoury, N. (2026) · Nature · doi:10.1038/d41586-026-00638-1

Conséquences pathologiques des dérégulations de la voie p53-DREAM : insuffisance médullaire, microcéphalie et cancer

Rakotopare, J. (2024) · doi:10.70675/cc79cc10zbaf8z4e88za003z8a8d37707576

Sexually Dimorphic RNA Helicase DDX3Y, But Not DDX3X, Plays a Potential Tumor-Suppressive Role in Colorectal Carcinogenesis in Males

Govatati, S., Malempati, S., Karnati, R., Syed, G. H., Ghosh, S., Tamanam, R. R., Bhanoori, M., & Rao, P. S. (2026) · Biochemical Genetics · doi:10.1007/s10528-026-11429-8

Cholesterol and p53 promote senescence and systemic fibrosis in metabolic dysfunction-associated steatohepatitisPreprint

Wittke, C. I., Watt, D. M., Butler, L., Lyons, A. M., Clarke, C. J., Mullen, C., Clements, N., Lawlor, A., Athineos, D., Young, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.02.748892

Multilayered mechanisms driving sexual dimorphism in antitumor immunity

Faisal, M., Abdelfattah, N., & Yun, K. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.09.007

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity

Haupt, S., & Haupt, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.632719 · Cited by 22 · see citing works

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies

Cardano, M., Buscemi, G., & Zannini, L. (2025) · Cells · doi:10.3390/cells14050363 · Cited by 3 · see citing works

A study of the impact of the X chromosome and the tumour suppressor TP53 on sex disparity in cancer

Guevara, F. C. (2025) · Minerva Access (University of Melbourne)

Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias

Dunford, A. J., Weinstock, D. M., Savova, V., Schumacher, S. E., Cleary, J. P., Yoda, A., Sullivan, T. J., Hess, J. M., Gimelbrant, A. A., Beroukhim, R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3726 · Cited by 459 · see citing works

X-linked Tumor Suppressor Escape and Sex Dimorphism in Cancer: Implications for Risk Stratification and Prevention

Han, S., & Kim, S. Y. (2026) · Journal of Cancer Prevention · doi:10.15430/jcp.26.041